Lorean Barrera v. Pharmavite LLC

  1. May 01, 2017

    Pharmavite Reaches $1.9M Settlement Over False Ad Claims

    Pharmavite LLC and its customers have agreed to a $1.9 million settlement to end claims the supplement maker falsely labeled its Nature Made brand glucosamine products.

  2. May 16, 2016

    Supplement Co. Seeks End To 'Gamesmanship' In Label Suit

    Pharmavite LLC on Friday continued to attack a consumer for allegedly changing her theory of which supposedly false statements on its Nature Made glucosamine supplements formed the basis of her class action, telling a California federal judge the two classes in the suit should be decertified and quick judgment should be granted.

  3. May 03, 2016

    Supplement Buyers Fight To Keep Class Cert. In False Ad Suit

    The lead consumer in a class action alleging Pharmavite LLC falsely labeled its Nature Made glucosamine supplements fought back Monday against the company's bid to decertify two purchaser groups, telling a California federal judge she hasn't once waivered on her claims.

  4. April 20, 2016

    Supplement Buyers Push To Keep False Ad Class Action Alive

    Purchasers of Pharmavite LLC's Nature Made glucosamine supplements urged a California federal court Tuesday to keep their false advertising class action alive, saying they've provided solid expert testimony regarding the company's claims of benefits to joint health.

  5. November 06, 2014

    Nature Made Supplement Buyers Near Cert. In False Ad Suit

    A California federal judge on Thursday said she was leaning toward certifying a class of purchasers of Pharmavite LLC's popular Nature Made brand glucosamine supplements, which plaintiffs allege provides none of the advertised benefits to joint health, saying it seems that question can be answered on a classwide basis.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!